In a nutshell, Agios Pharmaceuticals Inc (AGIO) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some of the hottest opportunities can be found in biotech ...
Wall Street Analysts Believe Agios Pharmaceuticals (AGIO) Could Rally 39.16%: Here's is How to Trade
S hares of Agios Pharmaceuticals (AGIO) have gained 1.9% over the past four weeks to close the last trading session at $25.87, but there could still be a solid upside left in the stock if short ...
AGIO stock has gone up by 1.36%, with a monthly decline of -1.06% and a quarterly surge of 37.64%. The volatility ratio for the week is 3.63%, and the volatility levels for the last 30 days are 3.67% ...
Avantgarde Finance Group has partnered with Agio Digital, a digital assets and fund platform, to launch an institutional-grade on-chain platform. The platform will allow users to establish fully ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Agios Pharmaceuticals Inc (NASDAQ: AGIO) says the Phase 3 ENERGIZE study of mitapivat in adults with non-transfusion-dependent (NTD) alpha- or beta-thalassemia achieved its primary Vandana ...
Future Proof, the award-winning B2B events company behind Future Proof Festival and Future Proof Retreat, today announced its ...
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback